No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CN Stock MarketDetailed Quotes
603259 WuXi AppTec
- 41.60
- -0.36-0.86%
Not Open Apr 25 15:00 CST
122.03BMarket Cap12.70P/E (TTM)
42.40High41.59Low716.88KlotVolume41.75Open41.96Pre Close3.00BTurnover2.82%Turnover Ratio12.70P/E (Static)2.93BShares93.5652wk High2.25P/B105.92BFloat Cap41.1752wk Low46.16Limit Up2.55BShs Float171.08Historical High37.76Limit Down1.93%Amplitude8.86Historical Low0.89Dividend TTM41.85Avg Price364.98KlotAsk2.15%Div YieldTTM100Lot Size353.69KlotBid
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 479,000 A shares on April 25
On April 25, Ge Longhui | Yao Ming Kangde (02359.HK) issued an announcement. On April 25, 2024, it spent RMB 2005 million yuan to repurchase 479,000 A shares, with a repurchase price of 41.6-42.39 yuan per share.
Yao Ming Kangde (02359) spent 2.046,800 yuan to buy back 475,800 A shares on April 24
Yao Ming Kangde (02359) issued an announcement to repurchase 475,800 A-shares with RMB 2.046,800 on April 24, 2024.
Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to Research
Yao Ming Kangde (02359) spent about 2.048,000 yuan to buy back 475,700 A shares on April 23
Yao Ming Kangde (02359) announced that on April 23, 2024, it cost about 2.048,000 yuan to buy back 47.5...
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 474,200 A shares on April 19
On April 19, Ge Longhui (02359.HK) issued an announcement. On April 19, 2024, it spent RMB 2005 million yuan to buy back 474,200 A shares, with a repurchase price of 41.88-42.9 yuan per share.
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
Comments
JUST IN:
China's January to February industrial profit grew by 10.2% y/y to 0.914 trillion yuan.
NBS:
Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.
Some 29 out of China's 41 main industries saw profits rise in the first two months.
$Alibaba(BABA.US$$BABA-SW(09988.HK$$TENCENT(00700.HK$$XIAOMI-W(01810.HK$$JD-SW(09618.HK$$BIDU-SW(09888.HK$$BYD COMPANY(01211.HK$$SENSETIME-W(00020.HK$$China Petroleum & Chemical Corporation(600028.SH$
NBS:
Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.Some 29 out of China's 41 main industries saw profits rise in the first two months.$Alibaba(BABA.US$$BABA-SW(09988.HK$$TENCENT(00700.HK$$XIAOMI-W(01810.HK$$JD-SW(09618.HK$$BIDU-SW(09888.HK$$BYD COMPANY(01211.HK$$SENSETIME-W(00020.HK$$China Petroleum & Chemical Corporation(600028.SH$
2
Wuxi Biologics Earnings Report: FY Net Income Misses Estimates Despite Revenue Surpassing Predictions
Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan.The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan.Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan.The gross margin for the c... 2
HSI Closes at 16,473, Down 25 pts
At close, $Hang Seng Index(800000.HK$ dropped 25 pts or 0.2% to 16,473. $Hang Seng TECH Index(800700.HK$ dropped 18 pts or 0.5% to 3,437. $Hang Seng China Enterprises Index(800100.HK$ fell 3 pts or 0.1% to 5,754. Market turnover reached $112.71 billion.
Active Heavyweights:
$MEITUAN-W(03690.HK$ closed at $93.3, up 5.7%
$HKEX(00388.HK$ closed at $231.6, down 2.8%
$PING AN(02318.HK$ closed at $32.65, down 2.4%
$AIA(01299.HK$ closed at $54.8, down 2.1%
$BABA-SW(09988.HK$ closed at...
Active Heavyweights:
$MEITUAN-W(03690.HK$ closed at $93.3, up 5.7%
$HKEX(00388.HK$ closed at $231.6, down 2.8%
$PING AN(02318.HK$ closed at $32.65, down 2.4%
$AIA(01299.HK$ closed at $54.8, down 2.1%
$BABA-SW(09988.HK$ closed at...
2
2
$WUXI APPTEC(02359.HK$ closed up by 5.7% and $WUXI BIO(02269.HK$ rose by 7.5% in Hong Kong on Monday after the departure of Mike Gallagher, chairman of the House Select Committee on the Chinese Communist Party, which could slow the legislation’s progress of the Biosecure Act.
$Hang Seng H-Share Index ETF(02828.HK$$Hang Seng Index(800000.HK$
$Hang Seng H-Share Index ETF(02828.HK$$Hang Seng Index(800000.HK$
1
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg